We bring new treatments to market, expand our existing products into new indications and regions where they address unmet medical need, and gather real-world evidence for available products.
Our R&D is focused on late-stage research within the areas of Haematology and Immunology, where our pre-market assets represent considerable value.
We provide access to innovative treatments that transform life for people.
Our therapies are concentrated within the areas of Haematology, Immunology and Specialty Care.
We contribute to societies by improving access to treatment of rare diseases.
Every day, we work actively to find better ways to understand and meet patient needs.
Find out more about our business and financial performance.
Here we present current and past media releases, images and videos.